Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Precision Biosciences Inc (DTIL)

Precision Biosciences Inc (DTIL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Kodiak Sciences (KOD) Q2 Earnings Beat, Eye Candidate in Focus

Kodiak Sciences (KOD) reports narrower-than-expected loss for the second quarter of 2022. The focus is on the lead candidate, KSI-301, which is being developed for treating various retinal vascular diseases....

REGN : 648.70 (+0.84%)
BAYRY : 13.7950 (+1.06%)
KOD : 11.81 (-1.99%)
DTIL : 1.99 (-3.40%)
Axsome (AXSM) Q2 Loss Narrower Than Expected, Revenues Miss

Axsome (AXSM) reports narrower-than-expected loss for the second quarter of 2022. The company records its first sales of the sleep drug, Sunosi, which it acquired from Jazz.

JAZZ : 158.72 (-0.96%)
TECH : 370.06 (-2.12%)
AXSM : 44.25 (-6.59%)
DTIL : 1.99 (-3.40%)
Acadia's (ACAD) Q2 Earnings & Revenues Surpass Estimates

Acadia (ACAD) reports a narrower-than-expected loss for the second quarter of 2022 while revenues surpass estimates. Tightens guidance for Nuplazid.

TECH : 370.06 (-2.12%)
ACAD : 16.96 (+2.17%)
ATRA : 4.94 (-7.49%)
DTIL : 1.99 (-3.40%)
Global Blood (GBT) to be Acquired by Pfizer, Misses on Earnings

Global Blood (GBT) is set to be acquired by Pfizer for around $5.4 billion. The company missed estimates for earnings while beating the same for revenues in the second quarter of 2022.

PFE : 49.86 (+0.22%)
TECH : 370.06 (-2.12%)
GBT : 67.00 (-0.06%)
DTIL : 1.99 (-3.40%)
Precision BioSciences (DTIL) Reports Q2 Loss, Misses Revenue Estimates

Precision BioSciences (DTIL) delivered earnings and revenue surprises of -2.33% and 23.80%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

DTIL : 1.99 (-3.40%)
ARCT : 20.44 (-5.68%)
Precision BioSciences Reports Second Quarter 2022 Financial Results and Provides Business Update

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced financial results...

DTIL : 1.99 (-3.40%)
Deciphera (DCPH) Loss Narrows in Q2, Qinlock Drive Revenues

Deciphera (DCPH) reports a narrower-than-expected loss in the second quarter of 2022 while revenues beat estimates. Shares rise.

BEAM : 63.56 (-9.60%)
ATRA : 4.94 (-7.49%)
DCPH : 15.85 (-4.75%)
DTIL : 1.99 (-3.40%)
Bayer (BAYRY) Earnings & Revenues Surpass Estimates in Q2

Bayer (BAYRY) beats estimates for both earnings and revenues in the second quarter of 2022.

REGN : 648.70 (+0.84%)
JNJ : 167.57 (+0.89%)
BAYRY : 13.7950 (+1.06%)
DTIL : 1.99 (-3.40%)
Editas' (EDIT) Loss Narrows in Q2, Revenues Trump Estimates

Editas (EDIT) reports a narrower-than-expected loss in the second quarter of 2022 while its revenues beat estimates. Focus remains on the lead candidate, EDIT-101.

BEAM : 63.56 (-9.60%)
ATRA : 4.94 (-7.49%)
EDIT : 17.34 (-6.07%)
DTIL : 1.99 (-3.40%)
Novo Nordisk's (NVO) Q2 Earnings Miss, Sales Beat Estimates

Novo Nordisk (NVO) missed estimates for earnings in the second quarter of 2022 while revenues beat the same, driven by growth in Diabetes and Obesity Care on higher GLP-1 revenues.

NVO : 105.32 (-0.99%)
BEAM : 63.56 (-9.60%)
ATRA : 4.94 (-7.49%)
DTIL : 1.99 (-3.40%)

Barchart Exclusives

3 Ways to Safely Play the Rebound In Automotive Retail   
Automotive retail stocks delivered huge gains on Aug. 16. The rebound over the past month doesn’t mean you have to miss out on the momentum play. Here are three ways to ride the wave while avoiding company-specific risk.  Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar